Cargando…

Healthcare Utilization and Costs in Sepsis Survivors in Germany–Secondary Analysis of a Prospective Cohort Study

Background: Survivors of sepsis often face long-term sequelae after intensive care treatment. Compared to the period of hospitalization, little is known about the ambulatory healthcare utilization in sepsis patients. The study evaluated healthcare utilization and associated costs of sepsis care incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Konrad F. R., Huelle, Katharina, Reinhold, Thomas, Prescott, Hallie C., Gehringer, Rebekka, Hartmann, Michael, Lehmann, Thomas, Mueller, Friederike, Reinhart, Konrad, Schneider, Nico, Schroevers, Maya J., Kosilek, Robert P., Vollmar, Horst C., Heintze, Christoph, Gensichen, Jochen S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879304/
https://www.ncbi.nlm.nih.gov/pubmed/35207415
http://dx.doi.org/10.3390/jcm11041142
_version_ 1784658866985762816
author Schmidt, Konrad F. R.
Huelle, Katharina
Reinhold, Thomas
Prescott, Hallie C.
Gehringer, Rebekka
Hartmann, Michael
Lehmann, Thomas
Mueller, Friederike
Reinhart, Konrad
Schneider, Nico
Schroevers, Maya J.
Kosilek, Robert P.
Vollmar, Horst C.
Heintze, Christoph
Gensichen, Jochen S.
author_facet Schmidt, Konrad F. R.
Huelle, Katharina
Reinhold, Thomas
Prescott, Hallie C.
Gehringer, Rebekka
Hartmann, Michael
Lehmann, Thomas
Mueller, Friederike
Reinhart, Konrad
Schneider, Nico
Schroevers, Maya J.
Kosilek, Robert P.
Vollmar, Horst C.
Heintze, Christoph
Gensichen, Jochen S.
author_sort Schmidt, Konrad F. R.
collection PubMed
description Background: Survivors of sepsis often face long-term sequelae after intensive care treatment. Compared to the period of hospitalization, little is known about the ambulatory healthcare utilization in sepsis patients. The study evaluated healthcare utilization and associated costs of sepsis care including allied health professions after initial hospitalization. Methods: Secondary analysis was performed on data in 210 sepsis patients prospectively enrolled from nine intensive care study centers across Germany. Data was collected via structured surveys among their Primary care (Family-) physicians (PCPs) within the first month after discharge from ICU (baseline) and again at 6, 12 and 24 months after discharge, each relating to the period following the last survey. Costs were assessed by standardized cost unit rates from a health care system’s perspective. Changes in healthcare utilization and costs over time were calculated using the Wilcoxon rank-sum test. Results: Of the 210 patients enrolled, 146 (69.5%) patients completed the 24 months follow-up. In total, 109 patients were hospitalized within the first 6 months post-intensive care. Mean total direct costs per patient at 0–6 months were €17,531 (median: €6047), at 7–12 months €9029 (median: €3312), and at 13–24 months €18,703 (median: €12,828). The largest contributor to the total direct costs within the first 6 months was re-hospitalizations (€13,787 (median: €2965). After this first half year, we observed a significant decline in inpatient care costs for re-hospitalizations (p ≤ 0.001). PCPs were visited by more than 95% of patients over 24 months. Conclusions: Sepsis survivors have high health care utilization. Hospital readmissions are frequent and costly. Highest costs and hospitalizations were observed in more than half of patients within the first six months post-intensive care. Among all outpatient care providers, PCPs were consulted most frequently. Clinical impact: Sepsis survivors have a high healthcare utilization and related costs which persist after discharge from hospital. Within outpatient care, possible needs of sepsis survivors as physiotherapy or psychotherapy seem not to be met appropriately. Development of sepsis aftercare programs for early detection and treatment of complications should be prioritized.
format Online
Article
Text
id pubmed-8879304
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88793042022-02-26 Healthcare Utilization and Costs in Sepsis Survivors in Germany–Secondary Analysis of a Prospective Cohort Study Schmidt, Konrad F. R. Huelle, Katharina Reinhold, Thomas Prescott, Hallie C. Gehringer, Rebekka Hartmann, Michael Lehmann, Thomas Mueller, Friederike Reinhart, Konrad Schneider, Nico Schroevers, Maya J. Kosilek, Robert P. Vollmar, Horst C. Heintze, Christoph Gensichen, Jochen S. J Clin Med Article Background: Survivors of sepsis often face long-term sequelae after intensive care treatment. Compared to the period of hospitalization, little is known about the ambulatory healthcare utilization in sepsis patients. The study evaluated healthcare utilization and associated costs of sepsis care including allied health professions after initial hospitalization. Methods: Secondary analysis was performed on data in 210 sepsis patients prospectively enrolled from nine intensive care study centers across Germany. Data was collected via structured surveys among their Primary care (Family-) physicians (PCPs) within the first month after discharge from ICU (baseline) and again at 6, 12 and 24 months after discharge, each relating to the period following the last survey. Costs were assessed by standardized cost unit rates from a health care system’s perspective. Changes in healthcare utilization and costs over time were calculated using the Wilcoxon rank-sum test. Results: Of the 210 patients enrolled, 146 (69.5%) patients completed the 24 months follow-up. In total, 109 patients were hospitalized within the first 6 months post-intensive care. Mean total direct costs per patient at 0–6 months were €17,531 (median: €6047), at 7–12 months €9029 (median: €3312), and at 13–24 months €18,703 (median: €12,828). The largest contributor to the total direct costs within the first 6 months was re-hospitalizations (€13,787 (median: €2965). After this first half year, we observed a significant decline in inpatient care costs for re-hospitalizations (p ≤ 0.001). PCPs were visited by more than 95% of patients over 24 months. Conclusions: Sepsis survivors have high health care utilization. Hospital readmissions are frequent and costly. Highest costs and hospitalizations were observed in more than half of patients within the first six months post-intensive care. Among all outpatient care providers, PCPs were consulted most frequently. Clinical impact: Sepsis survivors have a high healthcare utilization and related costs which persist after discharge from hospital. Within outpatient care, possible needs of sepsis survivors as physiotherapy or psychotherapy seem not to be met appropriately. Development of sepsis aftercare programs for early detection and treatment of complications should be prioritized. MDPI 2022-02-21 /pmc/articles/PMC8879304/ /pubmed/35207415 http://dx.doi.org/10.3390/jcm11041142 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schmidt, Konrad F. R.
Huelle, Katharina
Reinhold, Thomas
Prescott, Hallie C.
Gehringer, Rebekka
Hartmann, Michael
Lehmann, Thomas
Mueller, Friederike
Reinhart, Konrad
Schneider, Nico
Schroevers, Maya J.
Kosilek, Robert P.
Vollmar, Horst C.
Heintze, Christoph
Gensichen, Jochen S.
Healthcare Utilization and Costs in Sepsis Survivors in Germany–Secondary Analysis of a Prospective Cohort Study
title Healthcare Utilization and Costs in Sepsis Survivors in Germany–Secondary Analysis of a Prospective Cohort Study
title_full Healthcare Utilization and Costs in Sepsis Survivors in Germany–Secondary Analysis of a Prospective Cohort Study
title_fullStr Healthcare Utilization and Costs in Sepsis Survivors in Germany–Secondary Analysis of a Prospective Cohort Study
title_full_unstemmed Healthcare Utilization and Costs in Sepsis Survivors in Germany–Secondary Analysis of a Prospective Cohort Study
title_short Healthcare Utilization and Costs in Sepsis Survivors in Germany–Secondary Analysis of a Prospective Cohort Study
title_sort healthcare utilization and costs in sepsis survivors in germany–secondary analysis of a prospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879304/
https://www.ncbi.nlm.nih.gov/pubmed/35207415
http://dx.doi.org/10.3390/jcm11041142
work_keys_str_mv AT schmidtkonradfr healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT huellekatharina healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT reinholdthomas healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT prescotthalliec healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT gehringerrebekka healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT hartmannmichael healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT lehmannthomas healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT muellerfriederike healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT reinhartkonrad healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT schneidernico healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT schroeversmayaj healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT kosilekrobertp healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT vollmarhorstc healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT heintzechristoph healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT gensichenjochens healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy
AT healthcareutilizationandcostsinsepsissurvivorsingermanysecondaryanalysisofaprospectivecohortstudy